Chen Baohua of Huahai pharmaceutical: improve the hospital access mechanism of drugs through consistency evaluation
-
Last Update: 2019-03-06
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
As a deputy of the National People's Congress from the grass-roots level, it is my duty to work and live at the grass-roots level for a long time and reflect the most real social situation and public opinion from the perspective of the masses ——On March 4, Chen Baohua, deputy to the National People's Congress and chairman of Zhejiang Huahai Pharmaceutical Co., Ltd., introduced in an interview that this year he brought one proposal and four proposals focusing on high-quality development of the pharmaceutical industry, credit legislation, small and medium-sized micro enterprise financing and other fields Representative interview with Chen Baohua: to promote the high-quality development of the pharmaceutical industry, the 19th National Congress of the Party of building a pharmaceutical power made a major decision of "implementing the healthy China strategy", and to promote the maintenance of people's health to the height of the national strategy As a representative of the National People's Congress who has worked in the field of medicine for many years, Chen Baohua has his own unique views on promoting the high-quality development of the pharmaceutical industry "As an important industry related to the national economy and people's livelihood, the pharmaceutical industry is an important guarantee to implement the healthy China strategy and build a well-off society in an all-round way In recent years, under the strong leadership of the CPC Central Committee and the State Council, China's pharmaceutical industry has developed rapidly, and the market scale has surpassed Japan to become the second largest pharmaceutical market in the world " Chen Baohua believes that objectively, there is still a certain gap between China and the pharmaceutical power, and problems such as insufficient innovation ability and uneven quality of generic drugs are still prominent "We need to further deepen the reform of the medical and health system, promote the high-quality and healthy development of the pharmaceutical industry, and better meet the requirements of the people for high-quality drugs." Representative interview with Chen Baohua: suggestions on promoting high quality development of pharmaceutical industry and building a powerful pharmaceutical country A kind of According to the established quality and time limit requirements of generic drug conformity assessment, we should accelerate the promotion of generic drug conformity assessment A kind of We need to further improve the hospital access mechanism of generic drugs through consistency evaluation, so that domestic high-quality generic drugs and original research drugs can compete fairly on one platform A kind of We should improve the assessment and salary system for medical staff, make sure that the common people use high-quality and cheap domestic generic drugs, and reduce the burden of drug use for the common people A kind of We need to improve the mechanism of drug production process change and ensure that new technologies and equipment play an active role in improving drug quality and environmental protection.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.